Hippocalcin Regulates NMDA Receptor Function and Neuronal Activity Through Elavl3 in Mouse Hippocampal Neural...

Area of Science:

• Neuroscience
• Cell Biology
• Molecular Biology

Background:

• Hippocalcin (HPCA) is a neuron-enriched calcium-binding protein crucial for brain function.
• The role of HPCA in neural precursor cells and its impact on N-methyl-D-aspartate (NMDA) receptors are not well understood.
• NMDA receptors are vital for neurodevelopment, synaptic plasticity, and implicated in neurological disorders.

Purpose of the Study:

• To investigate the role of HPCA in regulating NMDA receptor expression and function in mouse hippocampal neural precursor cells (mHNPCs).
• To identify downstream pathways affected by HPCA in mHNPCs.

Main Methods:

• HPCA knockdown in mHNPCs.
• Analysis of NMDA receptor gene expression (e.g., Grin2C, Shank1, Serpine2).
• Measurement of NMDA-induced calcium signaling.
• Transcriptomic analysis to identify downstream targets.
• ELAV-like RNA-binding protein 3 (Elavl3) suppression experiments.
• In vivo HPCA knockdown in the hippocampus.

Main Results:

• HPCA knockdown significantly reduced NMDA receptor-related gene expression and attenuated NMDA-induced calcium signaling in mHNPCs.
• Transcriptomic analysis identified Elavl3 as a downstream target affected by HPCA knockdown.
• Elavl3 suppression mimicked HPCA deficiency, impairing NMDA receptor activity and neuronal differentiation.
• In vivo HPCA knockdown altered locomotor activity, contextual memory, and affective behaviors.

Conclusions:

• HPCA is essential for supporting NMDA receptor function and neuronal development in the hippocampus.
• HPCA exerts its effects, in part, through Elavl3-associated pathways.
• HPCA is identified as a key regulator of hippocampal function with implications for neurological conditions.